Over 70% of small-molecule therapeutics emerging from today's discovery pipelines are too poorly water-soluble to enable adequate bioavailability after oral intake. This solubility problem greatly hinders pharmaceutical development and ultimately prevents patients from accessing potentially life-saving treatments.
At Harpago, we tackle this solubility problem through rigorous formulation design and development. Our dosage forms are being used by pharmaceutical companies across the globe to enhance solubility and bioavailability in discovery, preclinical and early clinical projects.
Job openings
We do not have any job openings at the moment
Apply here
If you are the one who we are looking for, send us your CV and cover letter